Huakang Biomedical Holdings Company Limited reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was CNY 5.7 million compared to CNY 5.9 million a year ago. Net loss was CNY 0.941 million compared to CNY 0.26 million a year ago. Basic loss per share from continuing operations was CNY 0.0023 compared to CNY 0.0007 a year ago.
For the six months, sales was CNY 11.47 million compared to CNY 11.8 million a year ago. Net loss was CNY 1.46 million compared to CNY 0.941 million a year ago. Basic loss per share from continuing operations was CNY 0.0035 compared to CNY 0.0024 a year ago.